基质金属蛋白酶-9及其组织抑制物-1与颈动脉粥样斑块稳定性相关研究

目的: 探讨基质金属蛋白酶-9（MMP-9）、基质金属蛋白酶抑制剂-1（TIMP-1）、MMP-9/TIMP-1与脑梗死患者颈动脉粥样斑块稳定性的相关性。方法: 80例动脉粥样硬化性脑梗死患者按TCD微栓子检测结果分为微栓子阴性组70例和微栓子阳性组10例，20例正常人作为对照组，分别测定血浆MMP-9、TIMP-1水平。结果: 脑梗死患者血浆MMP-9、TIMP-1水平明显高于正常对照组(P<0.01)，相关性分析发现MMP-9水平与TIMP-1水平呈正相关（r=0.76，P<0.01）。MMP-9/TIMP-1比值仅在微栓子阳性组明显增高。结论: 血浆MMP-9参与了脑梗死的病理生理过程，血浆MMP-9和MMP-9/TIMP-1与颈动脉粥样斑块的不稳定性呈正相关。

Relationship between matrix metalloproteinase-9 and tissue metalloproteinase inhibitor-1 and carotid atheromatous plaque stability

AIM: To investigate the correlation between matrix metalloproteinase-9 (MMP-9),tissue metalloproteinase inhibitor-1 (TIMP-1),MMP-9/TIMP-1 and carotid atheromatous plaque stability in cerebral infarction patients.METHODS: 80 patients with cerebral infarction were categorized as microemboli-negative group (n=70) and microemboli-positive group (n=10),20 normal human were served as control group.The MMP-9 and TIMP-1 levels in plasma were determined by mean of ELISA in 3 groups.RESULTS: The levels of MMP-9 and TIMP-1 in plasma were significantly higher in cerebral infarction patients than those in control group (P<0.01).The plasma MMP-9 content was positively correlated with TIMP-1 content (r=0.76，P<0.01).The ratio of MMP-9/TIMP-1 increased only in microemboli-positive patients (P<0.01).CONCLUSION: The results indicate that the plasma MMP-9 participates in pathophysiological process of cerebral infarction.The ratio of MMP-9/TIMP-1 shows a close relationship with carotid atheromatous plaque instability.